Home • Life Sciences
Life Sciences
nanoCONTI – New Non-Batch Continuous Mixer Print E-mail
East-West-Report - Life Sciences
Thursday, 10 September 2009 08:08

nanoCONTI – New Non-Batch Continuous Mixer Hebold Mixing and More GmbH has announced an important new addition to its contiline family of non-batch continuous mixing equipment. Called the nanoCONTI, this state-of-the-art system for producing emulsions overcomes several well-known disadvantages of batch technology, including high energy, high material costs and uneven quality.

Read more...
 
CULTEX Impresses With New In-Vitro Testing Modules Print E-mail
East-West-Report - Life Sciences
Thursday, 10 September 2009 07:53

An Ames assay module for testing the mutagenic potency of airborne material after direct exposure of bacteria at the air/agar interface.Germany’s CULTEX is  a technological leader in the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. Called in-vitro testing (from ‘in vitro’, or literally ‘in glass’), these test methods are used primarily to identify potentially hazardous chemicals or to confirm a lack of toxicity during the early development of new drugs, agricultural chemicals or food additives. At CULTEX, the exposure strategy is a three-step process involving the generation of aerosols, exposure of cells and bacteria to those aerosols, and a subsequent analysis for toxicity, genotoxicity and other effects.

Read more...
 
CULTEX® RFS - First Choice in Running in-vitro Exposure Experiments Print E-mail
East-West-Report - Life Sciences
Friday, 14 August 2009 08:53

The new Cultex® RFS (Radial Flow System).Germany’s CULTEX is the technological leader in the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. The company’s special area of expertise is the characterization of the effects of inhalable, airborne substances on Cell lines and 3D cell constructs from the respiratory tract, including human donors.

Read more...
 
Medical Progress on a Humanitarian Basis Print E-mail
East-West-Report - Life Sciences
Friday, 14 August 2009 08:19

Rudolf W. Schötteldreier (Chairman of the Board of HC Berlin Pharma AG), Dr. Kwame (Nelson Mandela´s son-in-law) and Ottmar Geiger (CEO, HC Berlin Pharam AG).HC Berlin Pharma AG was formed early 2007 in Berlin. It has mainly specialised in thedevelopment,  manufacture and production of innovative pharmaceutical products. As a low risk pharmaceutical company it has developed and patented new ways  of administering pharmaceutical products who’s active agents are well known, have been tested and promise by these new methods greater effectiveness and healing power.

Read more...
 



Download

PDF-Download

Newsletter

TNI-Newsletter

Order your free copy now!

TECHNOLOGY NEWSletter